Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
YjeF N-terminal domain-containing protein 3 (YJEFN3) is a human protein encoded by the YJEFN3 gene and features a YjeF N-terminal domain, a fold associated with enzymatic activity in other proteins but whose specific function in YJEFN3 remains under investigation. It is predicted to catalyze NAD(P)HX epimerase activity. Functionally, it has been implicated in accelerating cholesterol efflux from endothelial cells to HDL and in regulating angiogenesis. YJEFN3 is also suggested to play a role in hematopoietic stem cell emergence via cholesterol metabolism signaling, and may participate in membrane raft distribution and gametogenesis. While not currently classified as a classical drug target (such as a receptor or enzyme with approved small molecule modulators), it is implicated in cell signaling and metabolic pathways linked to vascular and hematopoietic systems [5][6][2][1].
Not established, as no drugs are known to modulate YJEFN3 directly [5][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on YjeF N-terminal domain-containing protein 3 (YJEFN3).